ALKS vs GNRC · P/E 14, rev $1.56B vs P/E 82, rev $4.21B
Alkermes Plc (ALKS) versus Generac Holdings Inc (GNRC) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Generac Holdings Inc (GNRC) is a specialty industrial machinery company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported GNRC revenue for 2025-12-31 was $4.21B. Net income was $159.6M. Revenue was down 2.0% from 2024-12-31 to 2025-12-31. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
Not investment advice. Open the ALKS and GNRC stock pages for the full models.
Not investment advice.